Paper24508317
Molecular characterization of gallbladder cancer using somatic mutation profiling.
Javle M and 13 others. Hum Pathol, 2014. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. Molecular characterization of gallbladder cancer using somatic mutation profiling. Papers, record 24508317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24508317
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Mutational Analysis | Major topic |
| Gallbladder Neoplasms | Major topic |
| Gene Expression Profiling | Major topic |
| Mutation | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Formaldehyde | |
| High-Throughput Nucleotide Sequencing | |
| Humans | |
| Male | |
| Middle Aged | |
| Paraffin Embedding | |
| Tissue Fixation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| P50 CA098258 | NCI NIH HHS | United States | P50CA098258 | PubMed and NIH | NIH RePORTER |
| U01 CA168394 | NCI NIH HHS | United States | U01CA168394 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 27384460 | Meta-signature of mutated genes in gallbladder cancer: evidence based high throughput screening assays. | https://conductscience.org/library/papers/27384460 |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18296645 | Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. | Cancer Epidemiol Biomarkers Prev | 2008 | https://conductscience.org/library/papers/18296645 | PubMed |
| 2 | 15343276 | Gallbladder cancer: lessons from a rare tumour. | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15343276 | PubMed |
| 3 | 23589545 | Precision oncology: an overview. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23589545 | PubMed |
| 4 | 21119722 | Trial watch: success for crizotinib in ALK-driven cancer. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/21119722 | PubMed |
| 5 | 12607585 | Cellular and molecular biology of biliary tract cancers. | Surg Oncol Clin N Am | 2002 | https://conductscience.org/library/papers/12607585 | PubMed |
| 6 | 22327622 | Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. | Nat Med | 2012 | https://conductscience.org/library/papers/22327622 | PubMed |
| 7 | 19182786 | Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. | Nat Biotechnol | 2009 | https://conductscience.org/library/papers/19182786 | PubMed |
| 8 | 9262251 | Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. | J Natl Cancer Inst | 1997 | https://conductscience.org/library/papers/9262251 | PubMed |
| 9 | 23558953 | Identification of targetable FGFR gene fusions in diverse cancers. | Cancer Discov | 2013 | https://conductscience.org/library/papers/23558953 | PubMed |
| 10 | 20368543 | IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20368543 | PubMed |
| 11 | 19262900 | HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer. | Gastrointest Cancer Res | 2007 | https://conductscience.org/library/papers/19262900 | PubMed |
| 12 | 20564624 | Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. | Cancer | 2010 | https://conductscience.org/library/papers/20564624 | PubMed |
| 13 | 15863030 | Cellular signaling by fibroblast growth factor receptors. | Cytokine Growth Factor Rev | 2005 | https://conductscience.org/library/papers/15863030 | PubMed |
| 14 | 23264629 | The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23264629 | PubMed |
| 15 | 22837387 | Transforming fusions of FGFR and TACC genes in human glioblastoma. | Science | 2012 | https://conductscience.org/library/papers/22837387 | PubMed |
| 16 | 22180306 | Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. | Oncologist | 2012 | https://conductscience.org/library/papers/22180306 | PubMed |
| 17 | 16699861 | Promoter methylation profile in gallbladder cancer. | J Gastroenterol | 2006 | https://conductscience.org/library/papers/16699861 | PubMed |
| 18 | 22968062 | Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. | Ann Surg | 2012 | https://conductscience.org/library/papers/22968062 | PubMed |
| 19 | 20133500 | IDH1 gene mutations: a new paradigm in glioma prognosis and therapy? | Oncologist | 2010 | https://conductscience.org/library/papers/20133500 | PubMed |
| 20 | 23648296 | [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing]. | Zhonghua Zhong Liu Za Zhi | 2013 | https://conductscience.org/library/papers/23648296 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42645890 | From Anatomical Staging to Precision Prognostication: Evolution of Gallbladder Cancer Staging Across AJCC Editions and the 2025 UICC TNM Update. | J Pers Med | 2026 | https://conductscience.org/library/papers/42645890 | PubMed |
| 42193406 | Revealing the Potential Associations of Mutation-Related Genes with Lymph Node Metastasis in Gallbladder Cancer Through Transcriptome and Exome Sequencing. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193406 | PubMed |
| 42050078 | Olfactomedin 4 orchestrates TGF-β/CEACAM6 axis, promoting cell-autonomous epithelial to mesenchymal transition during gallbladder epithelium carcinogenesis. | Oncogene | 2026 | https://conductscience.org/library/papers/42050078 | PubMed |
| 41520156 | Actionable genomic landscape of biliary tract cancer in the Indian population. | Oncologist | 2026 | https://conductscience.org/library/papers/41520156 | PubMed |
| 41207908 | Deciphering Cancer Evolution Through Genomic Profiling of Patient-Derived Xenograft Together with Matched Primary Gallbladder Cancer. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/41207908 | PubMed |
| 41178929 | Circulating tumor DNA in biliary tract cancers: A review of current applications. | World J Clin Oncol | 2025 | https://conductscience.org/library/papers/41178929 | PubMed |
| 41148618 | A Phase 2 Prospective Trial of Capecitabine Plus Oxaliplatin as First-Line Therapy for Advanced Gall Bladder Cancers. | Asian Pac J Cancer Prev | 2025 | https://conductscience.org/library/papers/41148618 | PubMed |
| 40257142 | Diagnostic accuracy of cfDNA levels in gallbladder cancer: A study using qPCR & threshold evaluation. | Indian J Med Res | 2025 | https://conductscience.org/library/papers/40257142 | PubMed |
| 40027313 | Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective. | J Liq Biopsy | 2024 | https://conductscience.org/library/papers/40027313 | PubMed |
| 39583123 | Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors. | Glob Med Genet | 2024 | https://conductscience.org/library/papers/39583123 | PubMed |
| 39366294 | Evolving therapeutic landscape of advanced biliary tract cancer: from chemotherapy to molecular targets. | ESMO Open | 2024 | https://conductscience.org/library/papers/39366294 | PubMed |
| 39262385 | What eliminates the chance for cure: a multi-center evaluation on 10-year follow-up of gallbladder cancer after surgical resection. | Ann Med | 2024 | https://conductscience.org/library/papers/39262385 | PubMed |
| 38972607 | TPPP-BRD9 fusion-related gallbladder carcinomas are frequently associated with intracholecystic neoplasia, neuroendocrine carcinoma, and a distinctive small tubular-type adenocarcinoma commonly accompanied with a syringomatous pattern. | Hum Pathol | 2024 | https://conductscience.org/library/papers/38972607 | PubMed |
| 37949943 | Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing. | Sci Rep | 2023 | https://conductscience.org/library/papers/37949943 | PubMed |
| 37444550 | Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37444550 | PubMed |
| 37251319 | Gallbladder cancer: current and future treatment options. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37251319 | PubMed |
| 36302789 | Gallbladder cancer. | Nat Rev Dis Primers | 2022 | https://conductscience.org/library/papers/36302789 | PubMed |
| 35326566 | Treatment of Resectable Gallbladder Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35326566 | PubMed |
| 35267556 | Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267556 | PubMed |
| 35207722 | Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. | J Pers Med | 2022 | https://conductscience.org/library/papers/35207722 | PubMed |
Genes95
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24508317
GET https://conductscience.org/api/papers/v1/24508317/references?page=2